Clinical trial
Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of…
NCT00368862 · Finnish Institute for Health and Welfare, Other · Completed
Key facts
| NCT number | NCT00368862 |
|---|---|
| Title | Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism. |
| Official title | Phase Four Double-Blind Randomized Comparative Study on Thestudy on the Efficacy of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism |
| Lead sponsor | Finnish Institute for Health and Welfare, Other |
| Collaborators | Finnish Foundation for Alcohol Studies |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alcoholism, Depression |
| Intervention type | Drug |
| Interventions | Ebixa (memantine hydrochloride), Cipralex (escitalopram) |
| Enrollment | 80 |
| Start date | Dec 1, 2005 |
| Completion | Jun 1, 2006 |
| First posted | Aug 29, 2006 |
| Last update posted | Aug 29, 2006 |
| Countries | Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: